Inj. Melkeran 50 mg

Inj. Melkeran 50 mg
Product Description

Inj. Melphalan 50 mg

Read more Show less

RMPL Pharma LLP

  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail
View company profile
Categories
more categories Show less

RMPL Pharma LLP

  • IN
  • 2018
    On CPHI since
  • 1 - 24
    Employees
Company types
Pharmaceutical company
Wholesale/Retail
View company profile

More Products from RMPL Pharma LLP (99)

  • VIVOTRUM GOLD WOMEN (100 + 20 TABLETS)

    Product VIVOTRUM GOLD WOMEN (100 + 20 TABLETS)

    MULTIVITAMIN & MULTIMINERAL
  • VIVOTRUM GOLD WOMEN (60TABLETS)

    Product VIVOTRUM GOLD WOMEN (60TABLETS)

    MULTIVITAMIN & MULTIMINERAL
  • WELL DIABET

    Product WELL DIABET

    DIABETIC FORMULA
  • VITAMIN-C complex

    Product VITAMIN-C complex

    VITAMIN-C complex
  • Inj. Canzatax 100 mg

    Product Inj. Canzatax 100 mg

    Inj. Paclitaxel 100 mg
  • INJ. CARMENDAN 12.5 MG

    Product INJ. CARMENDAN 12.5 MG

    LIVOSIMENDAN 12. MG INJECTION.
  • Tab. Low-K

    Product Tab. Low-K

    POTASSIUM CHLORIDE TABLETS
  • Ves-ATRA Softgel

    Product Ves-ATRA Softgel

    Tretinoin Soft Gelatin Capsules.
  • INJ. MELKERAN 50 MG

    Product INJ. MELKERAN 50 MG

    - PALLIATIVE TREATMENT OF MULIPLE MYELOMA.- PALLIATION OF NON - RESECTABLE EPITHELIAL CARCINOMA OF THE OVARY .
  • TAB. MELKERAN 2 MG

    Product TAB. MELKERAN 2 MG

    - PALLIATIVE TREATMENT OF MULIPLE MYELOMA.- PALLIATION OF NON - RESECTABLE EPITHELIAL CARCINOMA OF THE OVARY .
  • INJ.LEUCOVORIN CALCIUM 50 MG

    Product INJ.LEUCOVORIN CALCIUM 50 MG

    - AN ACTIVE METABOLITE OF FOLIC ACID  ( ALSO CALLED  FOLINIC ACID AND CICTROVORUM FACTOR ), WHICH DOSE NOT REQUIRE METABOLISM BY DIHYDROFOLATE REDUCTASE , THE MOLECULAR TARGET OF FOLATE ANTAGONIST- TYPE CHEMOTHERAPEUTIC DRUGS.
  • INJ. HOLOFOS 2 MG

    Product INJ. HOLOFOS 2 MG

    - INDICATED FOR USE IN COMBINATION WITH CERTAIN OTHER APPROVED ANTI NEOPLASTIC AGENT FOR THIRD - LINE CHEMOTHERAPY OF GERMS CELL TESTICULAR CANCER.- IFOSFAMIDE IS COMBINED IS COMBINED WITH MESNA FOR PROPHYLAXIS OF HEMORRHAGIC CYSTITIS.
show all 99 other products

RMPL Pharma LLP resources (1)

  • RMPL PHARMA LLP.

    Brochure RMPL PHARMA LLP.

    The primary goal of RMPL PHARMA LLP. is to supply our consumers with pharmaceutical products by providing assurance regarding their performance safety, value and consistency. The commitment to quality is well rooted in corporate values of our company and is very essential to our continuous development & success.